Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_382ccfc2ebebcaee15aa7cda4cee86bc |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-183 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-737 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-728 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-737 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-728 |
filingDate |
2012-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41c48777b06fd1627bda9199ec93cb29 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25a4766b59c44837bd4a34ac5247739a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3bdf44e36589e656c204d4e28c3c1a91 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ed60981f4d765b27e084c83c5805794 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a4fa9dcacb349a17139909671e4b04b |
publicationDate |
2014-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2014294991-A1 |
titleOfInvention |
Medicament for treating anterior eye disease comprising rebamipide and a tear-retaining agent |
abstract |
The present invention provides a combination of rebamipide and a tear-retaining agent as a medicament for the treatment of anterior eye diseases. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2706353-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10918725-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017057973-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018264120-A1 |
priorityDate |
2011-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |